CHRISTIE KONEN: Open Payments
NPI 1992402085 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,439 in 64 payments from 20 companies in 2025. Trend: 2023 $517 · 2024 $1,590 · 2025 $1,439
Food & beverage: $1,439
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 12 | $323 |
| Novo Nordisk Inc | 11 | $172 |
| Medtronic, Inc. | 6 | $153 |
| Xeris Pharmaceuticals, Inc. | 5 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $85 |
| Ascendis Pharma Endocrinology Inc | 4 | $79 |
| Lilly USA, LLC | 4 | $76 |
| Dexcom, Inc. | 2 | $64 |
| Sequel Med Tech, LLC | 2 | $63 |
| Abbott Laboratories | 2 | $45 |
Products named: iLet Bionic Pancreas, MINIMED 780G, GVOKE HYPOPEN, Ozempic, Kerendia, Yorvipath, Dexcom G6 Transmitter, TWIIST.
Industry payments across FL — which companies pay providers there.
